Whalegun
Home

Mark Rothera, President and CEO: Viracta Therapeutics VIRX Buy · Filed 23/12/04

Trade details

Type
Insider buy
Amount
$25,526.06
Shares · price
52,094 sh · $0.49 a share
Held after
52,094 sh
Stock
Viracta Therapeutics VIRX
Person
Mark RotheraPresident and CEO
Trade date
23/11/30
Filed
23/12/04
Days to filing
4 days

First purchase

Insiders buying this week
1 insiders

Viracta Therapeutics trades, last 26 weeks

What else happened in Viracta Therapeutics around then

Filed or reported within 30 days of the trade day · 23/10/31~23/12/30

Mark Rothera's recent trades

  • Mark Rothera

    BuyViracta Therapeutics

    $23.5K

    Filed 23/12/04

Mark Rothera, CEO — bought $25.5K of Viracta Therapeutics VIRX · 52,094 sh @ $0.49 | Whalegun